Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.

Bioconjugate chemistry - 19 May 2010

Yang Qiang, Li Cishan, Wei Yadong, Huang Wei, Wang Lai-Xi

Abstract excerpt

The third variable (V3) domain of HIV-1 gp120 envelope glycoprotein is critical for HIV-1 entry and represents an attractive target for vaccine design. There are three conserved N-glycans within or around the V3 loop. The N295 and N332 glycans at the base of V3 are usually characterized as high-mannose type in gp120, and the N301 glycan is a complex type. We report in this paper the expression and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Broadly Neutralizing Antibodies

Share to Carbohydrate Sequence

Share to Glycosylation

Share to HIV Antibodies

Share to HIV Envelope Protein gp120

Share to Immunoglobulin G

Source

Open in PubMed Open full text

Identifiers

PMID: 20369886
DOI: 10.1021/bc9004238
PMCID: PMC2901909

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.PMID 20369886Read ↗

Identification of a broad and potent V3 glycan site bNAb targeting an N332 <sub>gp120</sub> glycan-independent epitopeSemantic proximity Read ↗

Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 coreSemantic proximity Read ↗

N463 Glycosylation Site on V5 Loop of a Mutant gp120 Regulates the Sensitivity of HIV-1 to Neutralizing Monoclonal Antibodies VRC01/03.Semantic proximity Read ↗

The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120Semantic proximity Read ↗

A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralizationSemantic proximity Read ↗

Alternative substitutions of N332 in HIV-1 AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycanSemantic proximity Read ↗

N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of FunctionSemantic proximity Read ↗

New insights of glycosylation role on variable domain of antibody structuresSemantic proximity Read ↗

Effect of ADCC-enhancing mutations on N-glycan profiles of human IgG1 antibodies.Semantic proximity Read ↗

Functional Characterization of Two scFv-Fc Antibodies from an HIV Controller Selected on Soluble HIV-1 Env Complexes: A Neutralizing V3- and a Trimer-Specific gp41 AntibodySemantic proximity Read ↗

Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.Semantic proximity Read ↗

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibodySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.